News

Nearly 1.3 Million Cancer Deaths Predicted for Europe in 2011


 

FROM ANNALS OF ONCOLOGY

The investigators noted in their analysis that among the study’s weaknesses was the fact that its predictions were short term and could be affected by unexpected events. Also, they wrote, "These predictions are based on the most recent trends in available data." However, "if a change, or even a reversal of trends, has taken place in the last 2 or 3 years," they cautioned, the regression model would not have picked it up.

The study by Dr. La Vecchia, Dr. Levi, and colleagues was funded by the Swiss Cancer League and the Italian Association for Cancer Research. The authors reported having no conflicts of interest.

Pages

Recommended Reading

FDA Clears iPhone/iPad App
MDedge Internal Medicine
Delay in Adjuvant Chemo Reduces Survival in Colorectal Cancer
MDedge Internal Medicine
AAD: Immunomodulators for Atopy Don't Increase Lymphoma Risk, Study Finds
MDedge Internal Medicine
FDA Asks ODAC to Ponder Shift Away From Single-Arm Studies
MDedge Internal Medicine
Hospital Occupancy Can Be Increased With Improved Surgery Scheduling
MDedge Internal Medicine
RADIANT Trials Show Benefit of Everolimus in Neuroendocrine Tumors
MDedge Internal Medicine
Axillary Lymph Node Dissection Doesn't Improve Breast Cancer Survival
MDedge Internal Medicine
Serial Screening Program Detects Nodular Melanomas
MDedge Internal Medicine
ASCO: Discuss Palliative Care, Symptom Relief With Cancer Patients Early
MDedge Internal Medicine
New-Onset Diabetes May Help Guide Pancreatic Cancer Screening
MDedge Internal Medicine